130 related articles for article (PubMed ID: 12453468)
1. Serum antibody response and nasal lymphoid tissue (NALT) structure in the absence of IL-4 or IFN-gamma.
Andoh A; Masuda A; Kumazawa Y; Kasajima T
Cytokine; 2002 Nov; 20(3):107-12. PubMed ID: 12453468
[TBL] [Abstract][Full Text] [Related]
2. Mucosal immunity of nasopharynx: an experimental study in TCR-transgenic (OVA23-3) mice.
Yamada T; Kataoka S; Ogasawara K; Ishimitsu R; Hashigucci K; Suzuki T; Kawauchi H
Rhinology; 2005 Sep; 43(3):190-8. PubMed ID: 16218512
[TBL] [Abstract][Full Text] [Related]
3. Lack of orally induced systemic unresponsiveness in IFN-gamma knockout mice.
Kweon MN; Fujihashi K; VanCott JL; Higuchi K; Yamamoto M; McGhee JR; Kiyono H
J Immunol; 1998 Feb; 160(4):1687-93. PubMed ID: 9469425
[TBL] [Abstract][Full Text] [Related]
4. Intranasal immunization with polymer-grafted microparticles activates the nasal-associated lymphoid tissue and draining lymph nodes.
Heritage PL; Brook MA; Underdown BJ; McDermott MR
Immunology; 1998 Feb; 93(2):249-56. PubMed ID: 9616375
[TBL] [Abstract][Full Text] [Related]
5. Induction of antibody-secreting cells and T-helper and memory cells in murine nasal lymphoid tissue.
Wu HY; Nikolova EB; Beagley KW; Russell MW
Immunology; 1996 Aug; 88(4):493-500. PubMed ID: 8881748
[TBL] [Abstract][Full Text] [Related]
6. A novel adenovirus expressing Flt3 ligand enhances mucosal immunity by inducing mature nasopharyngeal-associated lymphoreticular tissue dendritic cell migration.
Sekine S; Kataoka K; Fukuyama Y; Adachi Y; Davydova J; Yamamoto M; Kobayashi R; Fujihashi K; Suzuki H; Curiel DT; Shizukuishi S; McGhee JR; Fujihashi K
J Immunol; 2008 Jun; 180(12):8126-34. PubMed ID: 18523277
[TBL] [Abstract][Full Text] [Related]
7. Comparison of murine nasal-associated lymphoid tissue and Peyer's patches.
Heritage PL; Underdown BJ; Arsenault AL; Snider DP; McDermott MR
Am J Respir Crit Care Med; 1997 Oct; 156(4 Pt 1):1256-62. PubMed ID: 9351630
[TBL] [Abstract][Full Text] [Related]
8. Lipopolysaccharide Derived From the Lymphoid-Resident Commensal Bacteria
Wang Y; Hosomi K; Shimoyama A; Yoshii K; Nagatake T; Fujimoto Y; Kiyono H; Fukase K; Kunisawa J
Front Immunol; 2021; 12():699349. PubMed ID: 34276692
[No Abstract] [Full Text] [Related]
9. Cytokine mRNAs in the nasal-associated lymphoid tissue during influenza virus infection and nasal vaccination.
Matsuo K; Iwasaki T; Asanuma H; Yoshikawa T; Chen Z; Tsujimoto H; Kurata T; Tamura SS
Vaccine; 2000 Jan; 18(14):1344-50. PubMed ID: 10618531
[TBL] [Abstract][Full Text] [Related]
10. Intranasal vaccination of infant mice induces protective immunity in the absence of nasal-associated lymphoid tissue.
Sabirov A; Metzger DW
Vaccine; 2008 Mar; 26(12):1566-76. PubMed ID: 18281130
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic and functional differences between lymphocytes from NALT and nasal passages of mice.
RodrÃguez-Monroy MA; Rojas-Hernández S; Moreno-Fierros L
Scand J Immunol; 2007 Mar; 65(3):276-88. PubMed ID: 17309783
[TBL] [Abstract][Full Text] [Related]
12. Nasal lymphoid tissue (NALT) as a mucosal immune inductive site.
Wu HY; Nguyen HH; Russell MW
Scand J Immunol; 1997 Nov; 46(5):506-13. PubMed ID: 9393634
[TBL] [Abstract][Full Text] [Related]
13. Non-toxic Stx derivatives from Escherichia coli possess adjuvant activity for mucosal immunity.
Ohmura-Hoshino M; Yamamoto M; Yuki Y; Takeda Y; Kiyono H
Vaccine; 2004 Sep; 22(27-28):3751-61. PubMed ID: 15315856
[TBL] [Abstract][Full Text] [Related]
14. Ovalbumin-protein sigma 1 M-cell targeting facilitates oral tolerance with reduction of antigen-specific CD4+ T cells.
Suzuki H; Sekine S; Kataoka K; Pascual DW; Maddaloni M; Kobayashi R; Fujihashi K; Kozono H; McGhee JR; Fujihashi K
Gastroenterology; 2008 Sep; 135(3):917-25. PubMed ID: 18565333
[TBL] [Abstract][Full Text] [Related]
15. Analysis of IL-2, IL-4, and IFN-gamma-producing cells in situ during immune responses to protein antigens.
Bogen SA; Fogelman I; Abbas AK
J Immunol; 1993 May; 150(10):4197-205. PubMed ID: 8482832
[TBL] [Abstract][Full Text] [Related]
16. Kinetics of mouse antibody and lymphocyte responses during intranasal vaccination with a lipooligosaccharide-based conjugate vaccine.
Hirano T; Jiao X; Chen Z; Van Waes C; Gu XX
Immunol Lett; 2006 Nov; 107(2):131-9. PubMed ID: 17030407
[TBL] [Abstract][Full Text] [Related]
17. Isolation and characterization of mouse nasal-associated lymphoid tissue.
Asanuma H; Thompson AH; Iwasaki T; Sato Y; Inaba Y; Aizawa C; Kurata T; Tamura S
J Immunol Methods; 1997 Mar; 202(2):123-31. PubMed ID: 9107301
[TBL] [Abstract][Full Text] [Related]
18. Altered antibody production and helper T cell function in mice lacking chemokines CCL19 and CCL21-Ser.
Aritomi K; Kuwabara T; Tanaka Y; Nakano H; Yasuda T; Ishikawa F; Kurosawa H; Kakiuchi T
Microbiol Immunol; 2010 Nov; 54(11):691-701. PubMed ID: 21044143
[TBL] [Abstract][Full Text] [Related]
19. Immune responses and protection in different strains of aged mice immunized intranasally with an adjuvant-combined influenza vaccine.
Asanuma H; Hirokawa K; Uchiyama M; Suzuki Y; Aizawa C; Kurata T; Sata T; Tamura S
Vaccine; 2001 Jul; 19(28-29):3981-9. PubMed ID: 11427274
[TBL] [Abstract][Full Text] [Related]
20. Intranasal immunization with cytotoxic T-lymphocyte epitope peptide and mucosal adjuvant cholera toxin: selective augmentation of peptide-presenting dendritic cells in nasal mucosa-associated lymphoid tissue.
Porgador A; Staats HF; Itoh Y; Kelsall BL
Infect Immun; 1998 Dec; 66(12):5876-81. PubMed ID: 9826368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
